Pharmacokinetics of orally administered omeprazole in children

American Journal of Gastroenterology

Volumn 95, Issue 11, 2000, Pages 3101-3106

  Andersson, Tommy ^b   Hassall, Eric ^a   Lundborg, Per ^b   Shepherd, Ross ^b   Radke, Michael ^b   Marcon, Margaret ^b   Dalväg, Agneta ^b   Martin, Steve ^b   Behrens, Rolf ^b   Koletzko, Sibylle ^b   Becker, Michael ^b   Drouin, Eric ^b   Göthberg, Gunnar ^b  

^a ASTRAZENECA   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADOLESCENT; AGE; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; METABOLIC RATE; MULTICENTER STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SCHOOL CHILD; ULCER HEALING;

ADMINISTRATION, ORAL; ADOLESCENT; AGE FACTORS; ANTI-ULCER AGENTS; AREA UNDER CURVE; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGITIS, PEPTIC; GASTROESOPHAGEAL REFLUX; HALF-LIFE; HUMANS; INFANT; OMEPRAZOLE; PROTON PUMPS;

EID: 0033759927     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02049-9     Document Type: Article

References (26)

1. Gastroesophageal reflux disease
2. Barrett's esophagus: New definitions and approaches in children
3. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study
4. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux esophagitis
5. Omeprazole v. ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety
6. 2-receptor antagonists in treating patients with peptic stricture, and esophagitis
7. Safety and efficacy of omeprazole for severe gastroesophageal reflux in children
8. Omeprazole for treatment of chronic erosive esophagitis in children: A multicenter study of safety, tolerability and dose requirements
9. Omeprazole for severe reflux esophagitis in children
10. Effect of omeprazole in the treatment of refractory acid related disease in childhood: Endoscopic healing and twenty-four-hour intragastric acidity
11. Effect of omeprazole - A gastric proton pump inhibitor - On pentagastrin stimulated acid secretion in man
12. Determination of omeprazole and metabolites in plasma and urine by liquid chromatography
13. Pharmacokinetics of intravenous omeprazole in children
14. Drug disposition and action in infants and children
15. Pharmacogenetics in pediatrics: Implications for practice
16. Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators
17. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism
18. Oxidative metabolism of omeprazole in human liver microsomes: Cosegregation with S-mephenytoin 4'-hydroxylation
19. Maturation of caffeine metabolic pathways in infancy
20. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: In-vivo/in-vitro correlation and inducibility
21. The effect of age, gender, and sexual maturation on the caffeine breath test
22. Pharmacogenetics and development: Are infants and children at increased risk for adverse outcomes?
23. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms
24. Cytochrome P-450 expression in sudden infant death syndrome
25. Diazepam elimination in premature and full term infants, and children
26. The pharmacokinetics of single and repeated once-daily doses of 10, 20 and 40 mg omeprazole as enteric-coated granules